TP53 and neoplasm: However, the sensitivity of WEE1i was not affected by tumor homologous recombination repair (HRR) defects and may be associated with a complex of biomarkers of early entry into the S phase, including TP53 mutations, RB1 mutations, and CCND1 amplification [101].